Results 181 to 190 of about 861,631 (245)

Non‐HLA Antibody‐Associated Hyperacute Allograft Rejection Following Lung Transplantation

Pediatric Transplantation, Volume 30, Issue 9, September 2026.
ABSTRACT Background Pediatric‐onset pulmonary hypertension (PH) is a rare, progressive pulmonary vascular disease associated with high mortality. In cases unresponsive to pharmacological therapy with a severe cardiorespiratory phenotype, lung transplantation (LT) remains the final treatment option. Although LT for pediatric PH is considered a procedure
Justyna A. Karolak, Ernestina Melicoff, Nidhy P. Varghese, Przemyslaw Szafranski, Esra Yıldız Bölükbaşı, Erin E. McHugh, Sarah Nicholas, Peter Jindra, John Hicks, Eric D. Austin, Paweł Stankiewicz, George B. Mallory   +11 more
wiley   +1 more source

Revisiting CD8+ T Cells in Allergy: The Emerging Role of Tc2 Cells

Scandinavian Journal of Immunology, Volume 104, Issue 3, September 2026.
Tc2 CD8+ T cells in Type 2 inflammation: induction, tissue adaptation, metabolic programming, and therapeutic implications. Both naïve CD8+ T cells and pre‐committed Tc1 CD8+ T cells can be directed towards a Tc2 phenotype, characterised by secretion of the Type 2 cytokines IL‐4, IL‐5, IL‐9 and IL‐13, which in turn drive eosinophil recruitment, goblet ...
Sabrina de Souza Ferreira, Christopher Andrew Tibbitt   +1 more
wiley   +1 more source

Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens.

Blood
Fuchs KJ, van de Meent M, Honders MW, Khatri I, Kester MGD, Koster EAS, Koutsoumpli G, de Ru AH, van Bergen CAM, van Veelen PA, 't Hoen PAC, van Balen P, van den Akker EB, Veelken JH, Halkes CJM, Falkenburg JHF, Griffioen M.   +16 more
europepmc   +1 more source

The TCXpress lane to T-cell receptor-engineered T cells. [PDF]

Blood Adv
Biernacki MA.
europepmc   +1 more source

Minor histocompatibility antigen TCR-T. [PDF]

Blood Adv
Krakow EF, Bleakley M.
europepmc   +1 more source

Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling Donors. [PDF]

Bone Marrow Res, 2012
Dzierzak-Mietla M, Markiewicz M, Siekiera U, Mizia S, Koclega A, Zielinska P, Sobczyk-Kruszelnicka M, Kyrcz-Krzemien S.   +7 more
europepmc   +1 more source

Optimal donor selection for transplant to reduce GVHD risk and augment graft-versus-malignancy efficacy. [PDF]

Curr Opin Immunol
Shaffer BC, Shaw BE.
europepmc   +1 more source

Highlight of 2025: From binding prediction to molecular design-computational advances in TCR-pMHC prediction and targeting. [PDF]

Immunol Cell Biol
Maire KJ, Coquet JM.
europepmc   +1 more source

Major Histocompatibility Complex Class I Matching is Necessary but not Sufficient for Tolerance Induction to Vascularized Composite Allografts After Donor Hematopoietic Cell Transplantation. [PDF]

Transplant Direct
Manell E, Gunes ME, Merl S, Patwardhan S, Chauhan I, Hong J, Chen B, Jordache P, Almesalmy A, Ekanayake-Alper D, Hajosi D, Husain S, Wuu CS, Wright M, Bogue J, Rohde C, Shanmugarajah K, Cetrulo CL, Sachs DH, Weiner J.   +19 more
europepmc   +1 more source

Antibodies to Non-HLA Antigens and Their Role in Organ Transplant Rejection. [PDF]

Int J Immunogenet
Jaklová K, Vychytilová K, Glosová A, Slavcev A.   +3 more
europepmc   +1 more source